chrisvoncsefalvay/vaers-outcomes huggingface dataset:
booster; Pain in injection arm (from shoulder down); numbness and tingling in hand; numbness and tingling in hand; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 50 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 07Dec2021 13:15 (Lot number: 330308P) at the age of 50 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Prior IBS diagnoses" (unspecified if ongoing); "sinus" (unspecified if ongoing); "allergies" (unspecified if ongoing); "Allergies: oranges, Tomatoes" (unspecified if ongoing); "Allergies: Penicillin" (unspecified if ongoing). Concomitant medication(s) included: ECHINACEA PURPUREA; TYLENOL SINUS [CHLORPHENAMINE MALEATE;PARACETAMOL;PSEUDOEPHEDRINE HYDROCHLORIDE]; ADIPEX [FENOFIBRATE]; BIOTIN. Past drug history included: Erythromycin, reaction(s): "Allergy". Vaccination history included: Bnt162b2 (Dose Number: 2, Batch/Lot No: Er2613, Location of injection: Arm Left), administration date: 26Mar2021, when the patient was 49 years old, for Covid-19 immunization; Bnt162b2 (Dose Number: 1, Batch/Lot No: En6206, Location of injection: Arm Left), administration date: 05Mar2021, when the patient was 49 years old, for Covid-19 immunization. The following information was reported: IMMUNISATION (non-serious) with onset 08Dec2021 02:00, outcome "not recovered", described as "booster"; PAIN IN EXTREMITY (non-serious) with onset 08Dec2021 02:00, outcome "not recovered", described as "Pain in injection arm (from shoulder down)"; HYPOAESTHESIA (non-serious), PARAESTHESIA (non-serious) all with onset 08Dec2021 02:00, outcome "not recovered" and all described as "numbness and tingling in hand". Therapeutic measures were not taken as a result of immunisation, pain in extremity, hypoaesthesia, paraesthesia. Additional information: Adverse event: Pain in injection arm (from shoulder down) with numbness and tingling in hand. Since receiving booster 7 days ago. No covid prior vaccination and no covid tested post vaccination.  No follow-up attempts are possible. Follow-up attempts are completed. No further information is expected.
Extreme Tinnitus in Left Ear (initially noticed while walking out of clinic post injection, persists currently all day long without reprieve).  Dizziness, Nausea, Fatigue, Vertigo (initially noticed within 30 minutes of injection, dissipated over 48 hours).  Joint and muscle pain (initially noticed within one hour of injection, dissipated over 72 hours).  Chest pain best described as sharp stinging/stabbing around heart that worsens when taking a deep breath in (initially noticed upon waking the day following the injection, persists currently intermittently throughout the day but every day).
I had breakthrough case of Covid my symptoms fever chills body ache sore throat runny nose fatigue for about a week.
PERIPHERAL NEUROPATHY 2/24/2023  &  3/1/2023  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Patient went in to atypical rhythm junctions rhythm and atrial flutter and fib which was difficult to control. Our cardiologist says she?s been seeing a number of these post vaccine
Information has been received from a consumer concerning an approx 5-12 yr old child who in approx 1996-2003 was vaccinated with a dose of varicella virus vaccine live. Subsequently the pt experienced a mild case of chickenpox. Unspecified medical attention was sought. The pt subsequently recovered. There was no product quality complaint involved. Additional information has been requested.
This infant had an uncontrolled high pitch cry / Shriek for 3 hours after his vaccines.
Following 2 month shots, developed erythematous macular rash over neck, chest and fae.  Unstable to face in 10 weeks.
I started having pain under my armpit and some swelling, then pain went up to my armpit and swelling that it hurt when I have my arm next to my body! It disturbed my sleep and my daily comfort I had to keep my arm away or on a pillow at night. For two days I used heated pad and took the supplement Oregano oil (1 capsule/day)  as I suspected it was my lymph glands, the third day the pain was slight in my armpit and felt a little pain in my left shoulder blade.
H/o itching with Dilaudid, helps with Benadryl. Pt complained of itching, no visible rash or hives, no shortness of breath and throat swelling. Not scratching herself. Appears calm and comfortable and relaxed. Benadryl administered verbalized some relief and advised to go tot the ER if symptoms worsen. Pt denied chills/fever. Resp 18. Pulse 81. Bp 121/81
administered 6y-11yr moderna as a booster to a complete pfizer series to patient 11 years old. Mom stated patient only had a sire arm and some fatigue, "out hiking today."
Vaccine exposure during pregnancy; accidently received GARDASIL 9 instead of TDAP vaccine; severe fatigue; nasal congestion; This spontaneous prospective pregnancy report was received from a medical assistant via company representative and a consumer (the patient) concerning a 33-year-old female patient. No concurrent condition, medical history, or concomitant therapy was reported. The patient became pregnant with last menstrual period (LMP) of 26-FEB-2021 and estimated date of delivery (EDD) of 03-DEC-2021.   On 10-SEP-2021, the patient was accidently vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) (strength and dose were unknown; lot # T025369 has been verified to be a valid lot number, expiration date reported and confirm upon internal validation as 01-DEC-2022), intramuscularly for Human Papilloma virus prevention instead of diphtheria vaccine toxoid, pertussis vaccine acellular, tetanus vaccine toxoid (TDAP) at 28 weeks pregnant (wrong vaccine administered and vaccine exposure during pregnancy). On an unknown date in September 2021(reported as on the same week), she also received diphtheria vaccine toxoid (+) pertussis vaccine acellular (+) tetanus vaccine toxoid (TDAP) (strength, dose, frequency, route, indication, lot # and expiration date were unknown) and influenza vaccine (strength, dose, frequency, route, indication, lot # and expiration date were unknown).  In September 2021, after receiving vaccines, the patient experienced severe fatigue and nasal congestion. The patient did not know which vaccines caused the symptoms. The outcome of fatigue and nasal congestion was unknown. The outcome of wrong product administered was reported as not recovered (this is an inconsistence information). The pregnancy outcome was not provided. The causality assessment was not provided. combinationproductreport: Yes; brandname: GARDASIL 9 SYRINGE (DEVICE); commondevicename: HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast); productcode: FMF; devicetype: SYRINGE, PISTON (FMF); devicelotnumber: T025369; expirationdate: 01-DEC-2022; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet criteria for reportability
Received vaccine on 03/03/2003. broke out in hives on 03/03/2003 at 07:30pm. Had them still when she went to bed at 10:30pm. Gone at 07:00am on 03/04/2003. Back at 05:00pm on 03/04/2003. Applied Benadryl cream at 09:00pm. Fading at 10:00. Gone in am on 03/05/2003. Around face, stomach and neck.
tingling from the injection site towards the cervical spine; cannot raise left hand because of the pain; he needs to use the restroom more frequently; Chills; headache; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PARAESTHESIA (tingling from the injection site towards the cervical spine), PAIN IN EXTREMITY (cannot raise left hand because of the pain), MICTURITION URGENCY (he needs to use the restroom more frequently), CHILLS (Chills) and HEADACHE (headache) in a 44-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Lymphocytes (suffered from lowered number of t-lymphocytes). Concomitant products included DIOSMIN, HESPERIDIN (DETRALEX) for an unknown indication.    On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Mar-2021, the patient experienced INJECTION SITE PARAESTHESIA (tingling from the injection site towards the cervical spine), PAIN IN EXTREMITY (cannot raise left hand because of the pain), MICTURITION URGENCY (he needs to use the restroom more frequently), CHILLS (Chills) and HEADACHE (headache). On 30-Mar-2021, CHILLS (Chills) had resolved. At the time of the report, INJECTION SITE PARAESTHESIA (tingling from the injection site towards the cervical spine), PAIN IN EXTREMITY (cannot raise left hand because of the pain), MICTURITION URGENCY (he needs to use the restroom more frequently) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Patient reported for a second shot of Pfizer at a site that was providing both Moderna and Pfizer.  The patient was switched lines and received the Moderna vaccine as a second shot.  The patient is currently 17 and 11 months old.  No observable advers reactions were noted after 45 minutes of observation.
On 03.10.2021 I recieved a booster (3rd does) of PFIZER VACCINE BATCH#FG2872, and from that point my current tinnitus was significantly increased. This make my tinnitus become severe and have daily bad impact on my life.
2/1/23  I had an upper respiratory thing, like a head cold which got worse. I did an At Home COVID test and it was positive on 2/3/23.  I had a Telehealth with my doctor, and he prescribed Paxlovid. I started taking it that day.  About a week and a half later, I got a rebound COVID.  While getting over the rebound, I got long COVID. I coughed so hard I developed a hernia. I am scheduled for surgery tomorrow.
This case was reported by a nurse and described the occurrence of inappropriate age at vaccine administration in a 9-year-old female patient who received KINRIX (batch number KJ924, expiry date 22nd October 2015). Previously administered products included DTPA IPV (dose 1,2 and 3.). On an unknown date, the patient received KINRIX. On an unknown date, the patient received KINRIX. On an unknown date, an unknown time after receiving KINRIX, the patient experienced inappropriate age at vaccine administration. On an unknown date, the outcome of the inappropriate age at vaccine administration was unknown. Additional information received: A 9YO was inadvertently given KINRIX as the 4th dose of DTap and IPV as part of her catch-up vaccinations.
Within two days starting to have left severe shoulder and right shoulder pain. Unable to raise arms above head. Fatigue, lack of sleep, tiredness. About a week later  mild swelling in right wrist with bilateral hand pains and neck stiffness. All symptoms have continued to this day. Xrays taken indicate arthritic changes. Was active golfer before shot. Can not even grip or swing clubs anymore. Artritis creams do not help. Am on Aleve, Advil, Tylenol Excedring several time as a day now that helps some. Was not on them prior.
ON 11/4/99, the pt experienced "floaters" in her eye. She saw a physician, and a dx of retinal infiltrates was made. Blood tests and chest x-ray were normal. Follow up was received from a physician. The symptoms resolved without medication.  No further information is available.
Took typhoid oral; major headache, abdominal swelling, loss of appetite, nausea, diarrhea, extremely tired
Pt called pharmacy complaining of problems with taste and smell along with a cough.  No other symptoms were noted from pt.
The needle and broken neck/hub got stuck to child's leg/no injury involved/there was no injury involved the neck/hub came out seamlessly from the involved patient; Reporter called on behalf of a Nurse to report a PQC on 2 VAXNEUVANCE syringes from the same lot number that broke; Second breakage occurred on 9/22/2023 and it broke at the neck after administering it; First breakage occurred on 9/15/2023 and broke at the neck when the needle was being put on prior to administration; This spontaneous report was received from a nurse referring to a child of unknown age and gender. The patient's pertinent medical history, drug reactions/allergies, concurrent conditions and concomitant medications were not reported.   On 15-SEP-2023 a pneumococcal 15v conj vaccine (crm197) (VAXNEUVANCE) syringe broke into two separate pieces (hub/neck and barrel) at the neck when the needle/hub was being put on, twisting on the needle, attempting to attach the needle, prior to administration and the nurse confirmed that she did not use the product (Syringe issue). On 22-SEP-2023, the patient was vaccinated with a dose of pneumococcal 15v conj vaccine (crm197) (VAXNEUVANCE) 0.5 milliliter injection, at a dose of 0.5 milliliter administered in the leg (reported as received full injection), lot # X012044 with expiration date 10-JAN-2025, for prophylaxis (vaccination scheme frequency, route of administration and specific anatomical location were not reported). It was reported that after the nurse administered the vaccine to the patient, the syringe broke off at the neck when removing the needle and the broken neck/hub got stuck to the child's leg (Syringe issue & poor quality device used) but no injury occurred (also reported as child was "ok") as the neck/hub came out seamlessly from the involved patient (No adverse event). The nurse confirmed there were no cracks, no evidence of damage, liquid in syringe tray, box was normal with no damage, and cellophane cover was intact.
3/23/22  "Felt weak but Got Better" 3/24/22  "Stomach pain, diarrhea"
redness; soreness; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (redness) and PAIN IN EXTREMITY (soreness) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, the patient experienced ERYTHEMA (redness) and PAIN IN EXTREMITY (soreness). At the time of the report, ERYTHEMA (redness) and PAIN IN EXTREMITY (soreness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.    Reporter did not allow further contact
Extremely high fever, light-headed, fainting, muscle aches, chills, nausea. Symptoms began at about 4 pm. By 8 pm, they were unbearable and fainting began. Fever broke at 11:30 pm after laying under cold towels and taking aspirin at 8 pm. Headache and fatigue lasted until noon Saturday (April 10)
Immediately after receiving Proquad/Kinrix and flu vaccine pt broke out in hives, cough, DIB, stidor, wheezing, angioedema face, lips - pt was give epinephrine 0.15mg, 10ml prednisone and 1tsp Benadryl, within 5 mins pt started to breathe easier.
Patient was fine immediately after receiving the vaccine but about 2 minutes later she started to feel like she was going to pass out. Her pupils dilated and her face drained of color, her lips turned purple, then she lost consciousness and arched her back, and took one long rattling breath. After that she started to regain consciousness and over the course of about 15 minutes  her color returned, her pupils became normal, she was able to walk and leave on her own.
Vomiting came first at around 530 pm, fever started around 7 and spiked at 102, lasted all night broke around 9 am the next day. Around 11 AM hives were noticed. During this time also there was alot of lethargy, body aches, headaches. Urination also didn't occur for nearly 24 hours after vaccination.
Information regarding PREVNAR was received from a consumer regarding a 4-month-old female patient who experienced administered the 2nd dose 1 month after the first dose, increased urine white blood cells and fever. The patient received the second dose on 25-Nov-2008. The patient also received a dose of DTaP (manufacturer unknown) and a dose of POLIO-vaccine (Not Specified) on 25-Nov-2008. The patient was administered the 2nd dose of PREVNAR 1 month after the first dose (inappropriate schedule of drug administration) on 25-Nov-2008. The patient has been experiencing a fever of 102.5 deg. F for the past two weeks (Dec-2008) Test results revealed increased urine white blood cells. Treatment included unspecified antibiotic. Outcome was reported as not recovered for the fever. The outcome for the increased urine white blood cells was unknown. No additional information was available at the time of this report.
No initial adverse effects. 8 days after injection, 2" diameter  sore, itchy, inflamed area at injection site developed .  Treated with ice pack and Tylenol.   Did not seek medical attention.  Reaction gone in 4 days.
Pt with fever to 101.3 (resolved with Tylenol) and involuntary jerking motions to the bilateral upper extremities lasting a few hours. Per the MD note she was also with complaint of her mind "moving slowly". This was noted in her delayed verbal response, She was able to follow all commands , able to perform finger to nose but noted with slight tremulousness, Overall by the time the MD saw the Patient at 01:30 AM on 4/3/21 she was improved per nursing and patient report. Neuro exam intact. No further jerking motions by early morning on 4/3/21.
Itching at injection site few hours after injection. Itching all over body, HA, fatigue and jittery began few hours post vaccination Treatment: Benadryl, Advil  Outcome: Itching improved, HA, improved, no change to jittery or fatigue. Does not interfere with ADLs
fainting spells; severe heart problems; can no longer walk up a flight of steps; Heart palpitations; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration in Jun2021 (Batch/Lot number was not reported) as dose 2, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient previously took the dose 1 of BNT162B2 on unspecified date for COVID-19 immunization. In Jun2021, the patient experienced fainting spells, severe heart problems, can no longer walk up a flight of steps, and heart palpitations. The patient got the second Pfizer vaccine in June. Since that the patient had severe heart problems. The patient can no longer walk up a flight of steps. The patient had fainting spells and heart palpitations. The outcome of the events was unknown.   The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow-up.
Fever, temp 99.8-100.1 for 48 hours, body aches, chills, loss of appetite, nausea diarrhea
This spontaneous report was received from a nurse refers to a female patient of unknown age. On an unknown date, the patient was vaccinated with GARDASIL. On an unknown date, the patient experienced premature ovarian failure. The patient reported that 2 of her cousins also experienced premature ovarian failure some time after receiving GARDASIL. The event of premature ovarian failure was considered as serious due to significant disability or incapacity. It was reported that when the response was requested, the representative stated that premature ovarian failure could present incapacity to become pregnant, at least temporarily for each patient. The outcome of the event premature ovarian failure was unknown. The reporter did not provide the causality between the event and the suspect drug. This is one of the two reports received from the same reporter. Additional information has been requested.
Within 2 hours after the first COVID shot I developed a dry cough that went away after 2 weeks.  I then had a second shot of COVID vaccine. 05/10/2021 shot to right arm vial 003C21A  I again developed a dry cough that has never gone away.  Not pregnant
Left foot became edematous, erythematous, and very painful.  Picture taken.  Almost appeared as if it were cellulitis.  This as standard seasonal flu.  Similar but more widespread multifocal reaction to second dose hepatitis B vaccination given in June 2009, which appeared in multiple sites.  Neither was related to the site of injection.
Swollen arm/ swollen under the armpit; Running a fever; Chills; Headache; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (Swollen arm/ swollen under the armpit), PYREXIA (Running a fever), CHILLS (Chills) and HEADACHE (Headache) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     Concomitant products included LISINOPRIL for an unknown indication.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced VACCINATION SITE SWELLING (Swollen arm/ swollen under the armpit), PYREXIA (Running a fever), CHILLS (Chills) and HEADACHE (Headache). The patient was treated with PARACETAMOL (TYLENOL EXTRA STRENGTH) on 05-Feb-2021 for Adverse event, at a dose. At the time of the report, VACCINATION SITE SWELLING (Swollen arm/ swollen under the armpit), PYREXIA (Running a fever), CHILLS (Chills) and HEADACHE (Headache) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Patient was administered vaccine that was improperly stored (in freezer for too long and considered expired by manufacturer at date of administration due to lack of study data). Patient revaccinated 6/5/22.
KINRIX and IPOL administered instead of DTAP so pt received 2 doses of polio vaccine.
THE DRUGS HE WAS GIVEN, THEY POISON HIM; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the patient experienced the drugs he was given, they poison him. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the drugs he was given, they poison him was not reported. This report was non-serious.
Pt complained of swelling in tongue and itching in tongue, mostly on L side. Given 25 mg PO benadryl with symptoms resolving prior to leaving